Trump administration to warn against using Tylenol due to autism risk
The Trump administration is planning to advise pregnant women against using Tylenol, citing a possible link between acetaminophen (the active ingredient in Tylenol) and an increased risk of autism in children, according to multiple reports. President Donald Trump’s upcoming announcement on autism will highlight these concerns and introduce a potential treatment involving the drug leucovorin, which is currently used to counteract certain cancer drug side effects and treat anemia. This announcement follows Health and Human Services Secretary Robert F. Kennedy Jr.’s promise to address the causes of what he calls an “autism epidemic” in the U.S.Earlier reports led to a sharp decline in Tylenol’s manufacturer stock price, although the company denies any connection between the drug and autism. Trump has described the forthcoming statement as a major medical breakthrough and hinted at having found answers regarding autism.
Trump administration to warn against using Tylenol due to autism risk
The Trump administration is set to advise pregnant women against taking Tylenol due to a possible link between the common painkiller and an increased risk of autism in children, according to multiple reports.
The Washington Post reported on Sunday night that President Donald Trump’s planned Monday announcement on autism will include raising new concerns about acetaminophen, the active ingredient in Tylenol, and its potential links to the disorder.
The press conference will also see the unveiling of a potential treatment for autism, specifically the drug leucovorin. According to Mayo Clinic, leucovorin is primarily used to combat the negative effects of a cancer medicine and treat certain kinds of anemia, or a deficiency in red blood cells.
The announcement makes due on a promise from Health and Human Services Secretary Robert F. Kennedy Jr. to find the cause of what he has called an “autism epidemic” in the country by sometime in September.
Both findings had already been teased earlier this month by the Wall Street Journal, leading to an immediate plunge in the stock price for Kenvue, the manufacturer of Tylenol. Spokespeople for the company have since maintained that there is no link between the over-the-counter drug and autism.
At the time, the outlet also said those findings would be filed in a larger HHS report, which was expected to be a review of existing research. According to Politico, no such report from Kennedy exists ahead of Monday’s presser, citing one unnamed senior Trump administration official.
TYLENOL STOCK PRICES PLUMMETS AS RFK JR. REPORTEDLY LINKS IT TO AUTISM
Still, Trump used part of his remarks at the funeral for Charlie Kirk earlier on Sunday to tease what he called “one of the biggest announcement[s] … medically, I think, in the history of our country.”
“I think you’re going to find it to be amazing. I think we found an answer to autism,” the president told the thousands who attended the memorial in Arizona.
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
